Targeting the Peptide Deformylase of Mycobacterium tuberculosis Leads to Drug Discovery

被引:4
|
作者
Singh, Vijai [1 ]
Somvanshi, Pallavi [1 ]
机构
[1] Bioinformat Ctr, Lucknow, Uttar Pradesh, India
关键词
Mycobacterium tuberculosis; Peptide deformylase; Docking; Phylogeny; Drugs;
D O I
10.2174/157018009789108286
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Peptide deformylase (PDF) is a ubiquitous bacterial metalloenzyme responsible to cleave the formyl group from nascent polypeptides, supporting in the maturation. It plays a vital role in the survival of bacterial cells which is conserved in the eubacteria and is considered to be an attractive target for developing new antibacterial agents. Homology modeling was employed for generation of 3-D structure of PDF of M. tuberculosis H37Rv and showed 92.5% amino acid in the allowed region of Ramachandran plot. PDF was used as target for a set of inhibitors with substantial structural differences. Docking results show that the BB-3497, BBS-54, Actinonin and BBS-02 bind with high affinity to enzyme active site. Phylogeny of PDF in M. tuberculosis H37Rv shows homology with other strains of pathogenic bacteria. These data validate PDF as a novel target for the design of a new generation of antimycobacterial agents.
引用
收藏
页码:487 / 493
页数:7
相关论文
共 50 条
  • [21] Drug targeting of heme proteins ion Mycobacterium tuberculosis
    McLean, Kirsty J.
    Munro, Andrew W.
    DRUG DISCOVERY TODAY, 2017, 22 (03) : 566 - 575
  • [22] Targeting the peptide deformylase of Salmonella enterica for virtual screening and structure based drug designing
    Somvanshi, P.
    Seth, P. K.
    NEW BIOTECHNOLOGY, 2009, 25 : S366 - S366
  • [23] The carboxy-terminal end of the peptide deformylase from Mycobacterium tuberculosis is indispensable for its enzymatic activity
    Saxena, R
    Chakraborti, PK
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 332 (02) : 418 - 425
  • [24] Glycine in the conserved motif III modulates the thermostability and oxidative stress resistance of peptide deformylase in Mycobacterium tuberculosis
    Narayanan, Sai Shyam
    Sokkar, Pandian
    Ramachandran, Murugesan
    Nampoothiri, Kesavan Madhavan
    FEMS MICROBIOLOGY LETTERS, 2011, 320 (01) : 40 - 47
  • [25] Mycobacterium tuberculosis Reporter Strains as Tools for Drug Discovery and Development
    Abramovitch, Robert B.
    IUBMB LIFE, 2018, 70 (09) : 818 - 825
  • [26] Characterizing septum inhibition in Mycobacterium tuberculosis for novel drug discovery
    Respicio, Laurel
    Nair, Pravin A.
    Huang, Qing
    Anil, Burcu
    Tracz, Sylvia
    Truglio, James J.
    Kisker, Caroline
    Raleigh, Daniel P.
    Ojima, Iwao
    Knudson, Dennis L.
    Tonge, Peter J.
    Slayden, Richard A.
    TUBERCULOSIS, 2008, 88 (05) : 420 - 429
  • [27] Implications of Mycobacterium tuberculosis Metabolic Adaptability on Drug Discovery and Development
    Cardoso, Nicole C.
    Chibale, Kelly
    Singh, Vinayak
    ACS INFECTIOUS DISEASES, 2022, 8 (03): : 414 - 421
  • [28] Antimycobacterial Metabolism: Illuminating Mycobacterium tuberculosis Biology and Drug Discovery
    Awasthi, Divya
    Freundlich, Joel S.
    TRENDS IN MICROBIOLOGY, 2017, 25 (09) : 756 - 767
  • [29] The Discovery of Antibacterial Natural Compound Based on Peptide Deformylase
    Liang, Li
    Zhou, Qianqian
    Hao, Zhixiang
    Wang, Fanfan
    Zhu, Yasheng
    Lin, Qisi
    Gao, Jian
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2018, 21 (04) : 292 - 297
  • [30] Dual targeting approach for Mycobacterium tuberculosis drug discovery: insights from DFT calculations and molecular dynamics simulations
    Ejalonibu, Murtala A.
    Elrashedy, Ahmed A.
    Lawal, Monsurat M.
    Soliman, Mahmoud E.
    Sosibo, Sphelele C.
    Kumalo, Hezekiel M.
    Mhlongo, Ndumiso N.
    STRUCTURAL CHEMISTRY, 2020, 31 (02) : 557 - 571